RxDoctor Payments Data

David Hiestand, MD

Sleep Medicine · Lexington, KYNPI 1588673370

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $196 and has fallen 68.8% since, to $61 in 2025. That places this record below the midpoint for sleep medicine clinicians in KY, where the typical reported total is $1,510.

$400in general payments, 2019–2025

Across 19 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idorsia Pharmaceuticals US Inc$87
  • Harmony Biosciences LLC$76
  • Jazz Pharmaceuticals Inc.$70
  • Avadel CNS Pharmaceuticals, LLC$47
  • Lilly USA, LLC$33
  • Azurity Pharmaceuticals, Inc.$17
  • plus $71 from 5 others

What the payments were for

  • Food & beverage$38596%
  • Education$154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$400 in reported general payments places this provider in the 30th percentile of 28 sleep medicine providers in Kentucky.

See all sleep medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$47,472
Medicare patients
227
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$64
Zolpidem Tartrate16$36

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →